Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01656317
Other study ID # 2011/2189.
Secondary ID ID:2011/2189.
Status Completed
Phase N/A
First received July 12, 2012
Last updated March 14, 2017
Start date January 1, 2012
Est. completion date December 20, 2015

Study information

Verified date March 2017
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study's main objective will be to assess which effect early initiated rehabilitation has on the frequency of complications and the level of physical and cognitive functioning after aneurysmal subarachnoid hemorrhage (SAH).

To this end the following aspects will be investigated:

The frequency of complications (with special emphasis on pulmonary complications,thromboembolic events, cerebral vasospasm, unintended discontinuation of drains and lines)

- Length of stay in hospitals and socio-economic impact

- Physical and cognitive function in the early and chronic phase after SAH

- Health-related quality of life and participation in society in the chronic phase


Description:

Oslo University Hospital (OUS) is the primary hospital for Health Region South-East regarding treatment of patients with SAH. Approximately 120 patients are referred annually. OUS,Rikshospitalet, Dept of Neurosurgery offers 24/7 service of surgical and vascular aneurysm repair performed by a dedicated vascular team.

Patients admitted in 2012 are treated in accordance to the standard institutional protocol plus an early rehabilitation model adapted to SAH, while patients admitted in 2011 who did not receive any early rehabilitation, but apart from that were treated identically, serve as a control group.

All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study. Examination of the patients from both 2011 and 2012 will be performed as part of routine, neurosurgical follow- up which is in the early phase at 3-6 months and in the chronic phase at least 12 months post SAH. Exclusion criteria for participation in the study: unsecured ruptured aneurysm, symptomatic aneurysm without rupture, previous SAH or brain injury, diagnosis of a neurodegenerative disorder, patients from other health regions or tourists, patients that were treated at the intensive care unit (ICU )only.


Recruitment information / eligibility

Status Completed
Enrollment 171
Est. completion date December 20, 2015
Est. primary completion date February 27, 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All patients admitted to the intermediate unit at OUS in 2011 and 2012 with aneurysmal SAH and repaired aneurysm will be invited to participate in this study.

Exclusion Criteria:

- Unsecured ruptured aneurysm,

- Symptomatic aneurysm without rupture

- Previous SAH or brain injury, diagnosis of a neurodegenerative disorder

- Patients from other health regions or tourists

- Patients that were treated at the intensive care unit (ICU )only.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Early multidisciplinary rehabilitation
Multidisciplinary rehabilitation consist of individualized stimulation and mobilisation. The multidisciplinary team consists of a physician, a nurse, a physiotherapist, an occupational therapist and a clinical neuropsychologist.

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Pain score on the Visual Analog Scale 3-6 and 12 months after SAH
Primary Glasgow Coma Scale (GCS) up to 10 weeks
Secondary Glasgow Outcome Scale Extended (GOSE) 3-6 months and 12 months after SAH
Secondary Functional Independence Measure (FIM) 3-6 months and 12 months after SAH
Secondary Coma Recovery Scale (CRS) 3-6 and 12 months after SAH
Secondary Disability Rating Scale (DRS) 3-6 and 12 months after SAH
Secondary High Level Mobility Assessment Tool (HIMAT) 3-6 and 12 months after SAH
See also
  Status Clinical Trial Phase
Recruiting NCT03754725 - Ferritin and Iron Burden in SAH sIRB Phase 1/Phase 2
Completed NCT01556620 - Is NIRS Able to Detect Ischemia Following Brain Insult N/A
Completed NCT01832389 - Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage N/A
Completed NCT04988932 - Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Intractable Cerebral Vasospasm N/A
Terminated NCT01343537 - Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects Phase 0
Completed NCT01569100 - Atorvastatin After Aneurysmal Subarachnoid Hemorrhage N/A